Tuhura Biosciences Inc (HURA)
Tuhura Biosciences stock today
Tuhura Biosciences closed at $1.93 on October 30, 2026, down 6.31% on the day. Over the past year it returned -22.2% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $123 million.
| Period | HURA | S&P 500 (SPY) |
|---|---|---|
| 1 month | -8.1% | -0.9% |
| 3 months | -11.1% | +2.1% |
| Year to date | +155.1% | +11.7% |
| 1 year | -22.2% | +12.4% |
| 3 years | -98.5% | +88.5% |
| 5 years | -99.9% | +76.0% |
Key statistics
- Market value
- $123M
- 52-week range
- $0.44 to $3.15
- Next report
- Nov 13, 2026 (estimated)
About Tuhura Biosciences
Develops cell therapy and regenerative medicine treatments.
Sector: Health Care
More on Tuhura Biosciences
- Returns: what $1,000 became$1,000 ten years ago is $0.02 today
No forecast, no recommendation. This page describes Tuhura Biosciences Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.